Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Michael White

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
The Annals of Pharmacotherapy|February 2, 2022
Pharmacists Have the Stats but No Provider Status: Now May Be Our MomentC Michael White
The Annals of Pharmacotherapy|April 18, 2014
3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderC Michael White
Nature Clinical Practice. Cardiovascular Medicine|December 19, 2007
Is dronedarone effective for the prevention of recurrent atrial fibrillation?C Michael White
The Annals of Pharmacotherapy|November 2, 2006
Ensuring that patients receive full cardiac pharmacotherapy services: a pharmacist's call to armsC Michael White
Journal of Clinical Pharmacology|May 23, 2019
Loperamide: A Readily Available but Dangerous Opioid SubstituteC Michael White
The Annals of Pharmacotherapy|April 14, 2023
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has ArrivedC Michael White
Journal of Clinical Pharmacology|May 21, 2016
Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-HydroxybutyrateC Michael White
The Annals of Pharmacotherapy|November 22, 2013
Pharmacists need recognition as providers to enhance patient careC Michael White
Journal of Clinical Pharmacology|April 1, 2016
Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health ImplicationsC Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2019
Pharmacologic and clinical assessment of kratom: An updateC Michael White
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
The Annals of Pharmacotherapy|February 2, 2022
Pharmacists Have the Stats but No Provider Status: Now May Be Our MomentC Michael White
The Annals of Pharmacotherapy|April 18, 2014
3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderC Michael White
Nature Clinical Practice. Cardiovascular Medicine|December 19, 2007
Is dronedarone effective for the prevention of recurrent atrial fibrillation?C Michael White
The Annals of Pharmacotherapy|November 2, 2006
Ensuring that patients receive full cardiac pharmacotherapy services: a pharmacist's call to armsC Michael White
Journal of Clinical Pharmacology|May 23, 2019
Loperamide: A Readily Available but Dangerous Opioid SubstituteC Michael White
The Annals of Pharmacotherapy|April 14, 2023
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has ArrivedC Michael White
Journal of Clinical Pharmacology|May 21, 2016
Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-HydroxybutyrateC Michael White
The Annals of Pharmacotherapy|November 22, 2013
Pharmacists need recognition as providers to enhance patient careC Michael White
Journal of Clinical Pharmacology|April 1, 2016
Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health ImplicationsC Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2019
Pharmacologic and clinical assessment of kratom: An updateC Michael White
Pageof 29